Prognosis of Posterior Lamellar Keratoplasty

Recruiting Observational Study
Fuchs' Endothelial Corneal Dystrophy Pseudophakic Bullous Keratopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Centre Hospitalier Régional Metz-Thionville · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Over the past decade, the management of Fuchs' endothelial corneal dystrophy (FECD) and pseudophakic bullous keratopathy (PBK) has been revolutionized by the development of posterior lamellar keratoplasty techniques: DSAEK and DMEK. DSAEK (Descemet Stripping Automated Endothelial Keratoplasty) involves replacing the patient's endothelium and pathological descemetum with a descemetic endothelial g…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients who received a posterior lamellar keratoplasty in Metz-Thionville Regional Hospital between 2012 and 2030 Exclusion Criteria: * patients refusing to take part in the study
Contacts

Arpiné EL NAR, PhD

0033387557766

projet-recherche-clinique@chr-metz-thionville.fr

CONTACT